The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions.
- DOI
- 10.1016/j.euroneuro.2023.04.008
- Published
- 2023 Aug
- Container
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.euroneuro.2023.04.008,
title = {The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions.},
author = {Gimbach S and Vogel D and Fried R and Faraone SV and Banaschewski T and Buitelaar J and Döpfner M and Ammer R},
year = {2023},
journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
doi = {10.1016/j.euroneuro.2023.04.008},
url = {https://doi.org/10.1016/j.euroneuro.2023.04.008}
}RIS
TY - JOUR TI - The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions. AU - Gimbach S AU - Vogel D AU - Fried R AU - Faraone SV AU - Banaschewski T AU - Buitelaar J AU - Döpfner M AU - Ammer R PY - 2023 JO - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology DO - 10.1016/j.euroneuro.2023.04.008 UR - https://doi.org/10.1016/j.euroneuro.2023.04.008 ER -
APA
S, G., D, V., R, F., SV, F., T, B., J, B., M, D., & R, A. (2023). The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2023.04.008
Source records
- pubmed · retrieved 2026-09-26T03:05:50.763Z